International Niemann–Pick Disease Alliance

Updates

  1. Chin Huei Wu (巫錦輝) [NPUK: My Story]

    Chin Huei Wu, gave a rousing presentation at the NPUK Annual Family Conference & Interactive Workshop (2017) in which he gave the story of his family’s life, living with Niemann-Pick disease: Subscribe to NPUK’s YouTube channel, to never miss...

    Read story
  2. CTD Holdings Receives Rare Pediatric Disease Designation for Trappsol® Cyclo™

    ALACHUA, FL – (Marketwired) – December 6, 2017 – CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, today announced that it has received rare...

    Read story
  3. Orphazyme’s CEO, Anders Hinsby: Letter to NP-C Community

    Available for download in English, French, German, Italian, Polish, and Spanish   Dear Niemann-Pick type C Community, We are pleased to inform you that on November 16th Orphazyme A/S was listed on the Nasdaq OMX exchange in Copenhagen through an...

    Read story
  4. New Treatment of Disease that Swells Organs Gives New Hope to 4-year-old Girl

    Medical geneticists at the Clinical Research Center of the Hospital de Clinicas in Porto Alegre are betting on an unprecedented treatment for a rare disease, known as ASMD Niemann-Pick disease type B. The disease has no cure, and causes...

    Read story
  5. Introducing the INPDR Facebook Page!

    We are happy to introduce the International Niemann-Pick Disease Registry (INPDR)’s official Facebook page – which will provide any and all relevant updates pertaining to the INPDR.  But, what is the INPDR? The INPDR is a unifying force that has...

    Read story
  6. Update #17 on the AIDNPC Clinical Programme

    Update #17 on the AIDNPC Clinical Programme (arimoclomol in treatment of Niemann-Pick disease type C) Available for download in English, French, German, Italian, Polish & Spanish   Interim information bulletin (following the Sept. 28th call) SUMMARY 001 Study: Conclusions and...

    Read story
  7. CTD Holdings Announces Approval of Clinical Trial Application to Conduct Phase I/II Clinical Study of Trappsol(R) Cyclo(TM) in Patients with Niemann-Pick Type C Disease in Israel

    Two New Israeli Sites Now Recruiting Patients in Multicenter European Trial Full press release available for download here ALACHUA, FL – (Marketwired) – September 18, 2017 – CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company developing cyclodextrin-based...

    Read story
  8. Ara Parseghian: 21/5/1923 – 2/8/2017

    We are sorry to share the sad news that Ara Parseghian, passed away yesterday. Ara was a former title winning coach of Notre Dame and founded the Ara Parseghian Medical Research Foundation, which has raised over $45million for research...

    Read story
  9. Development of Gene Therapy for NP-C (UCL)

    In the following video (provided courtesy of NPUK) Dr. Ahad A. Rahim: Lecturer in Translational Neuroscience & UCL Excellence Fellow in Neurological Disease Modelling, gives an excellent breakdown of what gene therapy is, and how it holds a lot...

    Read story
  10. 12th Annual ICORD Conference – 6th China Rare Disease Summit, 7th September 2017

    We are happy to announce the Niemann Pick Symposium, pre-conference satellite meeting to the 12th Annual ICORD Conference and 6th China Rare Disease Summit, will take place this year on the 7th September at the JW Mariott Hotel Beijing. The event,...

    Read story

Join the Registry

Calling all patients and carers! We've created a global registry of all NPD patients - if you're not enrolled yet, join us now...

The Impact of NPC

The global community tell their stories...